secwatch / observer
8-K/A filed April 6, 2023, 7:59 PM ET CIK 0001402479
other material confidence high sentiment neutral materiality 0.65

MedAvail Holdings, Inc.: M&A transaction — MedAvail substantially completes exit from pharmacy services; focuses on pharmacy tech business

MedAvail Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

MedAvail Holdings, Inc. completed a disposition involving German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, "CVS") for final purchase price of $2.9 million (closed 2023-02-10).

Action
disposition
Counterparty
German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, "CVS")
Consideration
final purchase price of $2.9 million
Closing
2023-02-10
Exact text from the filing
On February 10, 2023, the Company closed the CVS Transaction for a final purchase price of $2.9 million; subject to $0.1 million fees and a $0.2 million holdback.
View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR
accession 0001402479-23-000023
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.